These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19302814)

  • 41. Administration of zinc inhibits osteoclastogenesis through the suppression of RANK expression in bone.
    Hie M; Tsukamoto I
    Eur J Pharmacol; 2011 Oct; 668(1-2):140-6. PubMed ID: 21806983
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of insulin-like growth factor-I on the expression of osteoclasts and osteoblasts in the nasopremaxillary suture under different masticatory loading conditions in growing mice.
    Tokimasa C; Kawata T; Fujita T; Kaku M; Kohno S; Tsutsui K; Tenjou K; Ohtani J; Motokawa M; Tanne K
    Arch Oral Biol; 2003 Jan; 48(1):31-8. PubMed ID: 12615139
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combination of beta-cryptoxanthin and zinc has potent effects on apoptotic cell death and suppression of bone resorption-related gene expression in osteoclastic cells.
    Yamaguchi M; Uchiyama S
    Int J Mol Med; 2008 Aug; 22(2):221-8. PubMed ID: 18636177
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro.
    Morko J; Kiviranta R; Mulari MT; Ivaska KK; Väänänen HK; Vuorio E; Laitala-Leinonen T
    Bone; 2009 Apr; 44(4):717-28. PubMed ID: 19118660
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Roles of chemokine receptor CX3CR1 in maintaining murine bone homeostasis through the regulation of both osteoblasts and osteoclasts.
    Hoshino A; Ueha S; Hanada S; Imai T; Ito M; Yamamoto K; Matsushima K; Yamaguchi A; Iimura T
    J Cell Sci; 2013 Feb; 126(Pt 4):1032-45. PubMed ID: 23264747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Zebrafish scales respond differently to in vitro dynamic and static acceleration: analysis of interaction between osteoblasts and osteoclasts.
    Kitamura K; Takahira K; Inari M; Satoh Y; Hayakawa K; Tabuchi Y; Ogai K; Nishiuchi T; Kondo T; Mikuni-Takagaki Y; Chen W; Hattori A; Suzuki N
    Comp Biochem Physiol A Mol Integr Physiol; 2013 Sep; 166(1):74-80. PubMed ID: 23632157
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Osteoblasts subjected to mechanical strain inhibit osteoclastic differentiation and bone resorption in a co-culture system.
    Li J; Wan Z; Liu H; Li H; Liu L; Li R; Guo Y; Chen W; Zhang X; Zhang X
    Ann Biomed Eng; 2013 Oct; 41(10):2056-66. PubMed ID: 23609024
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypergravity effects on osteoclasts activity.
    Nemoto A; Uemura T
    J Gravit Physiol; 2000 Jul; 7(2):P127-8. PubMed ID: 12697500
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Parathyroid hormone-related protein is required for normal intramembranous bone development.
    Suda N; Baba O; Udagawa N; Terashima T; Kitahara Y; Takano Y; Kuroda T; Senior PV; Beck F; Hammond VE
    J Bone Miner Res; 2001 Dec; 16(12):2182-91. PubMed ID: 11760831
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Local application of statin promotes bone repair through the suppression of osteoclasts and the enhancement of osteoblasts at bone-healing sites in rats.
    Ayukawa Y; Yasukawa E; Moriyama Y; Ogino Y; Wada H; Atsuta I; Koyano K
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Mar; 107(3):336-42. PubMed ID: 18801677
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
    Kassem M
    APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Osteoblast protects osteoclast devoid of sodium-dependent vitamin C transporters from oxidative cytotoxicity of ascorbic acid.
    Takarada T; Hinoi E; Kambe Y; Sahara K; Kurokawa S; Takahata Y; Yoneda Y
    Eur J Pharmacol; 2007 Dec; 575(1-3):1-11. PubMed ID: 17698058
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Both mercury and cadmium directly influence calcium homeostasis resulting from the suppression of scale bone cells: the scale is a good model for the evaluation of heavy metals in bone metabolism.
    Suzuki N; Yamamoto M; Watanabe K; Kambegawa A; Hattori A
    J Bone Miner Metab; 2004; 22(5):439-46. PubMed ID: 15316864
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cathepsin K mRNA detection is restricted to osteoclasts during fetal mouse development.
    Dodds RA; Connor JR; Drake F; Feild J; Gowen M
    J Bone Miner Res; 1998 Apr; 13(4):673-82. PubMed ID: 9556067
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Osteoclast-specific Dicer gene deficiency suppresses osteoclastic bone resorption.
    Mizoguchi F; Izu Y; Hayata T; Hemmi H; Nakashima K; Nakamura T; Kato S; Miyasaka N; Ezura Y; Noda M
    J Cell Biochem; 2010 Apr; 109(5):866-75. PubMed ID: 20039311
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Osteoclastic activity induces osteomodulin expression in osteoblasts.
    Ninomiya K; Miyamoto T; Imai J; Fujita N; Suzuki T; Iwasaki R; Yagi M; Watanabe S; Toyama Y; Suda T
    Biochem Biophys Res Commun; 2007 Oct; 362(2):460-6. PubMed ID: 17714690
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanical strain effect on bone-resorbing activity and messenger RNA expressions of marker enzymes in isolated osteoclast culture.
    Kurata K; Uemura T; Nemoto A; Tateishi T; Murakami T; Higaki H; Miura H; Iwamoto Y
    J Bone Miner Res; 2001 Apr; 16(4):722-30. PubMed ID: 11316000
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of novel N-cyano-tetrahydro-pyridazine compounds, a class of cathepsin K inhibitors, on the bone resorptive activity of mature osteoclasts.
    Kim SH; Jhon DJ; Song JH; No JS; Kang NS
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3988-91. PubMed ID: 18571402
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rosmarinic acid exerts an antiosteoporotic effect in the RANKL-induced mouse model of bone loss by promotion of osteoblastic differentiation and inhibition of osteoclastic differentiation.
    Lee JW; Asai M; Jeon SK; Iimura T; Yonezawa T; Cha BY; Woo JT; Yamaguchi A
    Mol Nutr Food Res; 2015 Mar; 59(3):386-400. PubMed ID: 25380345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.